Terbutaline Sulfate

Terbutaline Sulfate
(ter byoo’ ta leen)
PREGNANCY CATEGORY B
Drug Classes
Antiasthmatic
Beta2-selective adrenergic agonist
Bronchodilator
Sympathomimetic
Tocolytic drug
Therapeutic Actions
In low doses, acts relatively selectively at beta2-adrenergic receptors to cause bronchodilation and relax the pregnant uterus; at higher doses, beta2 selectivity is lost and the drug acts at beta1 receptors to cause typical sympathomimetic cardiac effects.
Indications
  • Prophylaxis and treatment of bronchial asthma and reversible bronchospasm that may occur with bronchitis and emphysema in patients 12 yr and older
  • Unlabeled use: Tocolytic to prevent preterm labor
Available Forms
Tablets—2.5, 5 mg; injection—1 mg/mL
Dosages
Adults and patients older than 15 yr
Oral
5 mg PO tid at 6-hr intervals during waking hours. If side effects are pronounced, reduce to 2.5 mg tid. Do not exceed 15 mg/day.
Parenteral
0.25 mg subcutaneously into lateral deltoid area. If no significant improvement in 15–30 min, give another 0.25-mg dose. Do not exceed 0.5 mg/4 hr. If patient fails to respond to second 0.25-mg dose within 15–30 min, other therapeutic measures should be considered.
Pediatric patients
Oral

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Terbutaline Sulfate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access